Equities
  • Price (EUR)146.05
  • Today's Change0.20 / 0.14%
  • Shares traded0.00
  • 1 Year change+9.73%
  • Beta--
Data delayed at least 15 minutes, as of May 30 2023 08:20 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Masimo Corporation is a global technology company that develops and produces a range of industry monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. Its patient monitoring solutions incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities and consumers through its direct sales force, distributors and original equipment manufacturer partners. It has developed Masimo Signal Extraction Technology, which provides the capabilities of Measure-through Motion and Low Perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry. Its technology offerings also include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet and others.

  • Revenue in USD (TTM)2.30bn
  • Net income in USD118.20m
  • Incorporated1996
  • Employees4.00k
  • Location
    Masimo Corp52 DiscoveryIRVINE 92618United StatesUSA
  • Phone+1 (949) 297-7000
  • Fax+1 (949) 297-7499
  • Websitehttps://www.masimo.com/
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.